comprehensive -WSS

comprehensive

author：leisure time 2025-09-29 22:51:34 - browse：7835

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Medical experts exlpore how to eliminate bias in clinical algorithms

Wikipedia

WSS

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Medical experts exlpore how to eliminate bias in clinical algorithms

Biohaven protein

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Akili, maker of video game for ADHD, to be acquired for 34 million

hotspot

comprehensive

Wikipedia

Peter Hotez and the public health issue of online harassment

Biohaven protein

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Medicare proposal to cover medical devices draws a mixed reaction

Report: NIH

Drug repurposing or repositioning? The language matters

The simple reason for the increase in autism diagnosis

Cancer drug shortages should be causing more outrage

Biohaven protein

focus

UnitedHealth wins $3.3 billion takeover of Amedisys

Supreme Court strikes down Biden student loan forgiveness program

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Insmed lung disease drug hits target in key Phase 3 trial

Brazil's Jair Bolsonaro is barred from running for office until 2030

UnitedHealth wins $3.3 billion takeover of Amedisys

focus

leisure time

hotspot

explore